Scinovex
article Open AccessTop 1% cited

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of Oncology · 2015 · Vol. 26 · pp. v116–v125
Hervé TillyMaría Gomes da SilvaUmberto VitoloAndrew JackMichel MeignanArmando López‐GuillermoJan WalewskiM. AndréPeter JohnsonMichael PfreundschuhMarco Ladetto
Lymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchMedicineDiffuse large B-cell lymphomaLymphomaClinical PracticeOncologyInternal medicineFamily medicine

MeSH terms

HumansLymphoma, Large B-Cell, Diffuse

Funding

  • Amgen
  • Bristol-Myers Squibb
  • Pfizer
  • GlaxoSmithKline
  • Gilead Sciences
  • Teva Pharmaceutical Industries
  • Celgene
  • Genentech
  • Cilag
Citations
911
FWCI
47.20
field-weighted impact
References
114
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up · Scinovex